Venus Concept up on strong forecast, results

Venus Concept

28/03/2022 15:59

** Shares of medical technology company  VERO.O  up 4.3% at
$1.44 in early trading
    ** VERO forecasts FY22 revenue between $126 mln and $130
mln, compared to Refinitiv ests of $125.9 mln  urn:newsml:reuters.com:*:nASA035LU
    ** Co also posts Q4 revenue above estimates and
smaller-than-expected adjusted loss
    ** VERO sees FY22 revenue growing by nearly 20% to 23%
y-o-y, reflecting continued strong adoption in its body and hair
restoration franchises
    ** Stock down ~15% YTD

    

 (Reporting by Tiyashi Datta in Bengaluru)
 ((tiyashi.datta@thomsonreuters.com))